Utilization of activated U937 monocytic cells as a model to evaluate biocompatibility and biodegradation of synthetic calcium phosphate

Biomaterials
H BlottiereN Passuti

Abstract

The use of calcium phosphate biomaterials as a bone substitute necessitates the use of normative biocompatibility and biodegradation techniques which must be fast, simple and reproducible. In the present study, we have developed an in vitro model to study and to compare different calcium phosphate ceramics. After activation with 1,25-dihydroxy-vitamin D3 and phorbol 12,13-dibutyrate, the monoblastic U937 cells became multinucleated, expressed tartrate-resistant acid phosphatase and several markers of monocyte/macrophage differentiation. Activated U937 cells did not express the vitronectin receptor (VNR) (as revealed using monoclonal antibodies 23C6 or 13C2) but around 25% of the cells were strongly reactive with 211D, a novel monoclonal antibody that recognizes an osteoclast-specific membrane antigenic determinant. These cells remain active/viable with hydroxyapatite (HA) or beta-tricalcium phosphate (beta-TCP) ceramics. In conclusion, activated U937 cells are good candidates to use in a normative in vitro method to evaluate new biomaterials.

References

Mar 3, 1978·Science·A J KahnS L Teitelbaum
Nov 10, 1978·Calcified Tissue Research·J N Heersche
Nov 1, 1991·Calcified Tissue International·P N NelsonT J Chambers
Jan 1, 1991·Virchows Archiv. A, Pathological Anatomy and Histopathology·J KanehisaH Takeuchi
Mar 1, 1990·Endocrinology·L R ReidT J Martin
Mar 1, 1986·Calcified Tissue International·J L OwensD J McCarty
Sep 1, 1983·Journal of Biomedical Materials Research·C P KleinA van den Hooff
Sep 1, 1984·Calcified Tissue International·T J Chambers, M A Horton
Dec 1, 1984·Calcified Tissue International·R W EvansD J McCarty
Oct 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·Z Bar-ShavitA J Kahn
Jan 1, 1980·Calcified Tissue International·J H Dominguez, G R Mundy

❮ Previous
Next ❯

Citations

Sep 5, 2002·Journal of Biomedical Materials Research·Paul de VosHenk J Busscher
May 6, 2005·Clinical Oral Investigations·Mihaela Roxana CimpanHenning Lygre
Jul 18, 2000·Molecular Pathology : MP·P N NelsonP G Murray
Jan 31, 2014·Journal of Tissue Engineering and Regenerative Medicine·Rainer Detsch, Aldo R Boccaccini
Jul 28, 2010·Journal of Biomaterials Applications·Rainer DetschBarbara Leukers
Jun 9, 2004·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Efrat Yagil-KelmerD Mark Estes
Mar 16, 2017·The Journal of Venomous Animals and Toxins Including Tropical Diseases·Ricardo Teixeira AraujoRussolina Benedeta Zingali
Feb 24, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yue WuJoseph A Madri
Feb 6, 2020·International Journal of Molecular Sciences·Alexander SieberathKenny Dalgarno
Aug 29, 2007·Acta Biomaterialia·R DetschG Ziegler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Bioremediation (ASM)

Bioremediation is the treatment and removal of harmful pollutants or contaminants through the use of microorganisms. Discover the latest research here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.